Pancreatic Cancer Research

ResearcherArmy Medical UniversityActive in the last 2 years

Zhonghu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3961-2560; OpenAlex author ID A5102851031. Sources: OpenAlex.

Their work

Papers
13 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 4 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 13

  1. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma. Co-author DOI 10.2174/1386207326666230810142646↗
  2. Retraction of "SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis". Co-author DOI 10.1515/med-2023-0890↗
  3. Hypoxia-Induced miR-210 Promotes Endothelial Cell Permeability and Angiogenesis via Exosomes in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2022/7752277↗
  4. SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis. Co-author DOI 10.1515/med-2022-0418↗
  5. Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s13046-021-01902-0↗
  6. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s13046-019-1436-0↗
  7. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2018.04.035↗
  8. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-018-0237-9↗
  9. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer. Co-author DOI 10.1159/000495281↗
  10. Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor met… First author DOI 10.1186/s13046-018-0822-3↗
  11. MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1. First author DOI 10.18632/oncotarget.20692↗
  12. Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1. First author DOI 10.3892/ijo.2017.4018↗
  13. The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer. First author DOI 10.1186/s13000-015-0445-3↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaowu Li · 8 shared papers, 2015–2021 · strength 0.66
  2. Weidong Jin · 3 shared papers, 2022–2024 · strength 0.63
  3. Peng Jiang · 7 shared papers, 2015–2018 · strength 0.52
  4. Jianxin Zhang · 2 shared papers, 2022–2024 · strength 0.41
  5. Zhiyong Zhang · 2 shared papers, 2022–2023 · strength 0.40
  6. Jie Li · 4 shared papers, 2018 · strength 0.30
  7. Bin Zhong · 1 shared paper, 2024 · strength 0.23
  8. Tao Zhang · 1 shared paper, 2024 · strength 0.23
  9. Jianxin Zhang · 1 shared paper, 2023 · strength 0.22
  10. Weidong Jin · 2 shared papers, 2019–2021 · strength 0.21
  11. Shuguang Wang · 2 shared papers, 2019–2021 · strength 0.21
  12. Gang Quan · 1 shared paper, 2022 · strength 0.17
  13. Yaqin Wang · 1 shared paper, 2022 · strength 0.17
  14. Guo Wu · 1 shared paper, 2022 · strength 0.17
  15. Xiangde Liu · 2 shared papers, 2018 · strength 0.15
  16. Xin Zhao · 2 shared papers, 2018 · strength 0.15
  17. Yingqiang Xu · 2 shared papers, 2015–2017 · strength 0.13
  18. Guo Wu · 2 shared papers, 2015–2017 · strength 0.13
  19. Yan Xiang Chen · 1 shared paper, 2021 · strength 0.12
  20. Jin Yang · 1 shared paper, 2017 · strength 0.09
  21. Yan Chen · 1 shared paper, 2019 · strength 0.09
  22. Xi Zhang · 1 shared paper, 2017 · strength 0.08
  23. Tao Peng · 1 shared paper, 2018 · strength 0.08
  24. Xiaoya Wang · 1 shared paper, 2018 · strength 0.07
  25. Hui Liu · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.